Literature DB >> 25364988

"My friend said it was good LSD": a suicide attempt following analytically confirmed 25I-NBOMe ingestion.

Joji Suzuki1, Justin L Poklis, Alphonse Poklis.   

Abstract

A new class of synthetic hallucinogens called NBOMe has emerged, and reports of adverse effects are beginning to appear. We report on a case of a suicide attempt after LSD ingestion which was analytically determined to be 25I-NBOMe instead. Clinicians need to have a high index of suspicion for possible NBOMe ingestion in patients reporting the recent use of LSD or other hallucinogens.

Entities:  

Keywords:  LSD; NBOMe; hallucinogens; psychedelics

Mesh：

Substances：

Year:  2014        PMID： 25364988      PMCID： PMC4220298          DOI： 10.1080/02791072.2014.960111

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN： 0279-1072


  13 in total

1.  Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.

Authors:  Michael R Braden; Jason C Parrish; John C Naylor; David E Nichols
Journal:  Mol Pharmacol       Date:  2006-09-25       Impact factor: 4.436

2.  NBOMe - a very different kettle of fish . . .

Authors:  David G E Caldicott; Stephen J Bright; Monica J Barratt
Journal:  Med J Aust       Date:  2013-09-02       Impact factor: 7.738

3.  The NBOMe series: a novel, dangerous group of hallucinogenic drugs.

Authors:  Andrew Ninnemann; Gregory L Stuart
Journal:  J Stud Alcohol Drugs       Date:  2013-11       Impact factor: 2.582

4.  Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Neuropharmacology       Date:  2013-09-04       Impact factor: 5.250

5.  The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample.

Authors:  Will Lawn; Monica Barratt; Martin Williams; Abi Horne; Adam Winstock
Journal:  J Psychopharmacol       Date:  2014-02-24       Impact factor: 4.153

6.  Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.

Authors:  Justin L Poklis; Kelly G Devers; Elise F Arbefeville; Julia M Pearson; Eric Houston; Alphonse Poklis
Journal:  Forensic Sci Int       Date:  2013-10-18       Impact factor: 2.395

Review 7.  The pharmacology of lysergic acid diethylamide: a review.

Authors:  Torsten Passie; John H Halpern; Dirk O Stichtenoth; Hinderk M Emrich; Annelie Hintzen
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

8.  25C-NBOMe--new potent hallucinogenic substance identified on the drug market.

Authors:  Dariusz Zuba; Karolina Sekuła; Agnieszka Buczek
Journal:  Forensic Sci Int       Date:  2012-09-16       Impact factor: 2.395

9.  High-performance liquid chromatography tandem mass spectrometry method for the determination of 2CC-NBOMe and 25I-NBOMe in human serum.

Authors:  Justin L Poklis; Jezelle Charles; Carl E Wolf; Alphonse Poklis
Journal:  Biomed Chromatogr       Date:  2013-07-25       Impact factor: 1.902

10.  Severe clinical toxicity associated with analytically confirmed recreational use of 25I-NBOMe: case series.

Authors:  Simon L Hill; Tom Doris; Shiv Gurung; Stephen Katebe; Alexander Lomas; Mick Dunn; Peter Blain; Simon H L Thomas
Journal:  Clin Toxicol (Phila)       Date:  2013-06-04       Impact factor: 4.467
View more
  7 in total

Review 1.  Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.

Authors:  Joji Suzuki; Michael A Dekker; Erin S Valenti; Fabiola A Arbelo Cruz; Ady M Correa; Justin L Poklis; Alphonse Poklis
Journal:  Psychosomatics       Date:  2014-11-06       Impact factor: 2.386

2.  Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication.

Authors:  Justin L Poklis; Sara K Dempsey; Kai Liu; Joseph K Ritter; Carl Wolf; Shijun Zhang; Alphonse Poklis
Journal:  J Anal Toxicol       Date:  2015-10       Impact factor: 3.367

3.  Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.

Authors:  Justin L Poklis; Stephen A Raso; Kylie N Alford; Alphonse Poklis; Michelle R Peace
Journal:  J Anal Toxicol       Date:  2015-10       Impact factor: 3.367

4.  Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.

Authors:  Joshua S Elmore; Ann M Decker; Agnieszka Sulima; Kenner C Rice; John S Partilla; Bruce E Blough; Michael H Baumann
Journal:  Neuropharmacology       Date:  2018-03-01       Impact factor: 5.250

5.  Test-Retest Reliability and descriptive analyses of the Modified Important People and Activities (MIPA) Interview.

Authors:  William H Zywiak; Robert L Stout; Jordan M Braciszewski; Tyler B Wray; Richard Longabaugh
Journal:  Heroin Addict Relat Clin Probl       Date:  2016-04

6.  Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics.

Authors:  James D Sexton; Charles D Nichols; Peter S Hendricks
Journal:  Front Psychiatry       Date:  2020-02-11       Impact factor: 4.157

7.  25CN-NBOMe Metabolites in Rat Urine, Human Liver Microsomes and C.elegans-Structure Determination and Synthesis of the Most Abundant Metabolites.

Authors:  Anna Šuláková; Jitka Nykodemová; Petr Palivec; Radek Jurok; Silvie Rimpelová; Tereza Leonhardt; Klára Šíchová; Tomáš Páleníček; Martin Kuchař
Journal:  Metabolites       Date:  2021-03-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.